Alnylam Pharmaceuticals Stock Price on February 3, 2021
ALNY Stock | USD 143.80 2.27 1.55% |
Below is the normalized historical share price chart for Alnylam Pharmaceuticals extending back to May 28, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Alnylam Pharmaceuticals stands at 143.80, as last reported on the 24th of April, with the highest price reaching 147.49 and the lowest price hitting 143.52 during the day.
If you're considering investing in Alnylam Stock, it is important to understand the factors that can impact its price. Alnylam Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16% return per unit of risk over the last 3 months. Alnylam Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alnylam Pharmaceuticals' Risk Adjusted Performance of (0.09), standard deviation of 2.14, and Mean Deviation of 1.41 to double-check the risk estimate we provide.
At this time, Alnylam Pharmaceuticals' Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 7.2 B in 2024, despite the fact that Total Stockholder Equity is likely to grow to (209.6 M). . At this time, Alnylam Pharmaceuticals' Price Earnings To Growth Ratio is fairly stable compared to the past year. Price To Operating Cash Flows Ratio is likely to rise to 241.02 in 2024, whereas Price To Sales Ratio is likely to drop 12.42 in 2024. Alnylam Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of May 2004 | 200 Day MA 173.6234 | 50 Day MA 151.4672 | Beta 0.396 |
Alnylam |
Sharpe Ratio = -0.1611
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ALNY |
Estimated Market Risk
2.13 actual daily | 18 82% of assets are more volatile |
Expected Return
-0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Alnylam Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alnylam Pharmaceuticals by adding Alnylam Pharmaceuticals to a well-diversified portfolio.
Price Book 142.9249 | Enterprise Value Ebitda (81.96) | Price Sales 10.2709 | Shares Float 125.4 M | Wall Street Target Price 222.41 |
Alnylam Pharmaceuticals Valuation on February 3, 2021
It is possible to determine the worth of Alnylam Pharmaceuticals on a given historical date. On February 3, 2021 Alnylam was worth 163.8 at the beginning of the trading date compared to the closed value of 157.43. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Alnylam Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Alnylam Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alnylam Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Alnylam Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
04/11/2022 | 163.80 | 165.28 | 157.18 | 157.43 | 610,100 |
158.46 | 165.15 | 157.79 | 159.58 | 956,100 |
Backtest Alnylam Pharmaceuticals | | | Alnylam Pharmaceuticals History | | | Alnylam Pharmaceuticals Valuation | Next |
Alnylam Pharmaceuticals Trading Date Momentum on February 3, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Alnylam Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Alnylam Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Alnylam Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Alnylam financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Alnylam Pharmaceuticals Stock history
Alnylam Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alnylam is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alnylam Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alnylam Pharmaceuticals stock prices may prove useful in developing a viable investing in Alnylam Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 124.9 M | 70.4 M | |
Net Loss | -1 B | -967.1 M |
Alnylam Pharmaceuticals Quarterly Net Working Capital |
|
Alnylam Pharmaceuticals Stock Technical Analysis
Alnylam Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Alnylam Pharmaceuticals Period Price Range
Low | April 11, 2022
| High |
163.80 | 157.43 |
Alnylam Pharmaceuticals April 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Alnylam Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alnylam Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Alnylam Pharmaceuticals stock market strength indicators, traders can identify Alnylam Pharmaceuticals entry and exit signals to maximize returns
Accumulation Distribution | 29899.62 | |||
Daily Balance Of Power | (0.79) | |||
Rate Of Daily Change | 0.96 | |||
Day Median Price | 161.23 | |||
Day Typical Price | 159.96 | |||
Price Action Indicator | (6.98) | |||
Period Momentum Indicator | (13.63) |
Alnylam Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Alnylam Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Alnylam Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alnylam to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.09) | |||
Jensen Alpha | (0.39) | |||
Total Risk Alpha | (0.63) | |||
Treynor Ratio | (0.51) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alnylam Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Alnylam Stock analysis
When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Alnylam Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alnylam Pharmaceuticals. If investors know Alnylam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alnylam Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.52) | Revenue Per Share 14.637 | Quarterly Revenue Growth 0.312 | Return On Assets (0.05) | Return On Equity (15.01) |
The market value of Alnylam Pharmaceuticals is measured differently than its book value, which is the value of Alnylam that is recorded on the company's balance sheet. Investors also form their own opinion of Alnylam Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Alnylam Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alnylam Pharmaceuticals' market value can be influenced by many factors that don't directly affect Alnylam Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alnylam Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alnylam Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alnylam Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.